Fludarabine, cyclophosphamide, and rituximab as first-line treatment in patients with chronic lymphocytic leukemia: A long-term analysis of the German CLL Study Group (GCLLSG) registry.
Saved in:
| Title: | Fludarabine, cyclophosphamide, and rituximab as first-line treatment in patients with chronic lymphocytic leukemia: A long-term analysis of the German CLL Study Group (GCLLSG) registry. |
|---|---|
| Authors: | Kutsch N; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany., Giza A; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany., Robrecht S; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany., Stumpf J; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany., Federhen A; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany., Stoltefuß A; Evangelisches Krankenhaus Hamm, Hamm, Germany., Vehling-Kaiser U; ÜBAG MVZ Dr. Vehling-Kaiser GmbH, Landshut, Germany., Koenigsmann M; Onkologisches Ambulanzzentrum Hannover., Tausch E; Division of CLL, Department III of Internal Medicine, University Hospital Ulm, Ulm, Germany., Schneider C; Division of CLL, Department III of Internal Medicine, University Hospital Ulm, Ulm, Germany., Stilgenbauer S; Division of CLL, Department III of Internal Medicine, University Hospital Ulm, Ulm, Germany., Illmer T; Gemeinschaftspraxis Hämatologie-Onkologie, Dresden, Germany., Schlag R; Hämatologisch-Onkologische Schwerpunktpraxis Würzburg, Würzburg, Germany., Dörfel S; Onkozentrum Dresden Freiberg, Dresden, Germany., Gaska T; Klinik für Hämatologie und Onkologie, Brüderkrankenhaus St. Josef, Paderborn, Germany., Kiehl M; Medizinische Klinik I, Klinikum Frankfurt/Oder, Frankfurt, Germany., Müller-Hagen S; Praxis für Hämatologie und Onkologie in Hamburg, Hamburg, Germany., Moorahrend E; Zentrum für Hämatologie und Onkologie MVZ Porta Westfalica, Porta Westfalica, Germany., Linde H; MVZ für Blut und Krebserkrankungen Potsdam, Potsdam, Germany., Schlenska-Lange A; Barmherzige Brüder Krankenhaus Regensburg, Regensburg, Germany., von Tresckow J; Universitätsklinikum Essen, Essen, Germany., Fischer K; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany., Eichhorst B; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany., Hallek M; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany., Fink AM; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany. |
| Source: | European journal of haematology [Eur J Haematol] 2024 Aug; Vol. 113 (2), pp. 235-241. Date of Electronic Publication: 2024 May 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38693677 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Fludarabine, cyclophosphamide, and rituximab as first-line treatment in patients with chronic lymphocytic leukemia: A long-term analysis of the German CLL Study Group (GCLLSG) registry. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kutsch+N%22">Kutsch N</searchLink>; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Giza+A%22">Giza A</searchLink>; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Robrecht+S%22">Robrecht S</searchLink>; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Stumpf+J%22">Stumpf J</searchLink>; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Federhen+A%22">Federhen A</searchLink>; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Stoltefuß+A%22">Stoltefuß A</searchLink>; Evangelisches Krankenhaus Hamm, Hamm, Germany.<br /><searchLink fieldCode="AU" term="%22Vehling-Kaiser+U%22">Vehling-Kaiser U</searchLink>; ÜBAG MVZ Dr. Vehling-Kaiser GmbH, Landshut, Germany.<br /><searchLink fieldCode="AU" term="%22Koenigsmann+M%22">Koenigsmann M</searchLink>; Onkologisches Ambulanzzentrum Hannover.<br /><searchLink fieldCode="AU" term="%22Tausch+E%22">Tausch E</searchLink>; Division of CLL, Department III of Internal Medicine, University Hospital Ulm, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Schneider+C%22">Schneider C</searchLink>; Division of CLL, Department III of Internal Medicine, University Hospital Ulm, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Stilgenbauer+S%22">Stilgenbauer S</searchLink>; Division of CLL, Department III of Internal Medicine, University Hospital Ulm, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Illmer+T%22">Illmer T</searchLink>; Gemeinschaftspraxis Hämatologie-Onkologie, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Schlag+R%22">Schlag R</searchLink>; Hämatologisch-Onkologische Schwerpunktpraxis Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Dörfel+S%22">Dörfel S</searchLink>; Onkozentrum Dresden Freiberg, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Gaska+T%22">Gaska T</searchLink>; Klinik für Hämatologie und Onkologie, Brüderkrankenhaus St. Josef, Paderborn, Germany.<br /><searchLink fieldCode="AU" term="%22Kiehl+M%22">Kiehl M</searchLink>; Medizinische Klinik I, Klinikum Frankfurt/Oder, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Müller-Hagen+S%22">Müller-Hagen S</searchLink>; Praxis für Hämatologie und Onkologie in Hamburg, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Moorahrend+E%22">Moorahrend E</searchLink>; Zentrum für Hämatologie und Onkologie MVZ Porta Westfalica, Porta Westfalica, Germany.<br /><searchLink fieldCode="AU" term="%22Linde+H%22">Linde H</searchLink>; MVZ für Blut und Krebserkrankungen Potsdam, Potsdam, Germany.<br /><searchLink fieldCode="AU" term="%22Schlenska-Lange+A%22">Schlenska-Lange A</searchLink>; Barmherzige Brüder Krankenhaus Regensburg, Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22von+Tresckow+J%22">von Tresckow J</searchLink>; Universitätsklinikum Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Fischer+K%22">Fischer K</searchLink>; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Eichhorst+B%22">Eichhorst B</searchLink>; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Hallek+M%22">Hallek M</searchLink>; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Fink+AM%22">Fink AM</searchLink>; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228703985%22">European journal of haematology</searchLink> [Eur J Haematol] 2024 Aug; Vol. 113 (2), pp. 235-241. <i>Date of Electronic Publication: </i>2024 May 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Blackwell%22">Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8703985 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1600-0609 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209024441%22">09024441 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Haematol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38693677 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/ejh.14220 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 235 Titles: – TitleFull: Fludarabine, cyclophosphamide, and rituximab as first-line treatment in patients with chronic lymphocytic leukemia: A long-term analysis of the German CLL Study Group (GCLLSG) registry. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kutsch N – PersonEntity: Name: NameFull: Giza A – PersonEntity: Name: NameFull: Robrecht S – PersonEntity: Name: NameFull: Stumpf J – PersonEntity: Name: NameFull: Federhen A – PersonEntity: Name: NameFull: Stoltefuß A – PersonEntity: Name: NameFull: Vehling-Kaiser U – PersonEntity: Name: NameFull: Koenigsmann M – PersonEntity: Name: NameFull: Tausch E – PersonEntity: Name: NameFull: Schneider C – PersonEntity: Name: NameFull: Stilgenbauer S – PersonEntity: Name: NameFull: Illmer T – PersonEntity: Name: NameFull: Schlag R – PersonEntity: Name: NameFull: Dörfel S – PersonEntity: Name: NameFull: Gaska T – PersonEntity: Name: NameFull: Kiehl M – PersonEntity: Name: NameFull: Müller-Hagen S – PersonEntity: Name: NameFull: Moorahrend E – PersonEntity: Name: NameFull: Linde H – PersonEntity: Name: NameFull: Schlenska-Lange A – PersonEntity: Name: NameFull: von Tresckow J – PersonEntity: Name: NameFull: Fischer K – PersonEntity: Name: NameFull: Eichhorst B – PersonEntity: Name: NameFull: Hallek M – PersonEntity: Name: NameFull: Fink AM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2024 Aug Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1600-0609 Numbering: – Type: volume Value: 113 – Type: issue Value: 2 Titles: – TitleFull: European journal of haematology Type: main |
| ResultId | 1 |
